Investment Analysts’ Updated EPS Estimates for September 30th (3IN, ALDX, ASML, BRO, BRZE, BWXT, CNXC, DC, DCGO, DYN)
Investment Analysts’ updated eps estimates for Wednesday, September 30th: 3i Infrastructure (LON:3IN) had its hold rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Aldeyra Therapeutics (NASDAQ:ALDX) had its neutral rating reissued by analysts at HC Wainwright. The firm currently has a $2.00 price target on the stock. ASML (NASDAQ:ASML) had its neutral rating reaffirmed […]
Investment Analysts’ Updated EPS Estimates for September 22nd (ABVX, ALKS, AM, ATLANTIC, ATLC, BEAT, BRBY, BUR, CWK, DAVA)
Investment Analysts’ updated eps estimates for Tuesday, September 22nd: Abivax (NASDAQ:ABVX) had its overweight rating reaffirmed by analysts at Barclays PLC. Barclays PLC currently has a $148.00 target price on the stock. Alkermes (NASDAQ:ALKS) had its outperform rating reissued by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $56.00 price […]
Stock Analysts’ Updated EPS Estimates for September 18th (ACET, ADSK, ARDT, AS, AXSM, BAM, BCBP, BPT, BROS, CLF)
Stock Analysts’ updated eps estimates for Friday, September 18th: Adicet Bio (NASDAQ:ACET) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $27.00 price target on the stock. Autodesk (NASDAQ:ADSK) had its buy rating reissued by analysts at BTIG Research. The firm currently has a $300.00 price target on the stock. […]
last updated on 30 Sep 18:11